During the past decade, Mid-Columbia Medical Center/Celilo Cancer Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 11 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 4 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mid-Columbia Medical Center/Celilo Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 7 trials as a collaborator, "NRG Oncology" with 5 trials as a collaborator, "SWOG Cancer Research Network" with 3 trials as a collaborator, "Cancer and Leukemia Group B" with 2 trials as a collaborator and "NCIC Clinical Trials Group" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Mid-Columbia Medical Center/Celilo Cancer Center" are "Clear Cell Renal Cell Carcinoma" (2 trials), "Colorectal Cancer" (2 trials), "Lung Cancer" (2 trials), "Prostate Cancer" (2 trials) and "Stage III Renal Cell Cancer AJCC v7" (2 trials). Many other conditions were trialed in "Mid-Columbia Medical Center/Celilo Cancer Center" in a lesser frequency.

Most popular intervention types in "Mid-Columbia Medical Center/Celilo Cancer Center" are "Drug" (11 trials), "Other" (10 trials), "Biological" (6 trials) and "Radiation" (6 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (7 trials), "Quality-of-Life Assessment" (5 trials), "Bevacizumab" (2 trials), "Docetaxel" (2 trials) and "Gemcitabine Hydrochloride" (2 trials). Other intervention names were less common.

The vast majority of trials in "Mid-Columbia Medical Center/Celilo Cancer Center" are 10 trials for "All" genders, 3 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Mid-Columbia Medical Center/Celilo Cancer Center". undefined are not yet recruiting, undefined are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Mid-Columbia Medical Center/Celilo Cancer Center, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Mid-Columbia Medical Center/Celilo Cancer Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".